BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16297202)

  • 1. Role of tetraspanins CD9 and CD151 in primary melanocyte motility.
    García-López MA; Barreiro O; García-Díez A; Sánchez-Madrid F; Peñas PF
    J Invest Dermatol; 2005 Nov; 125(5):1001-9. PubMed ID: 16297202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetraspanins are localized at motility-related structures and involved in normal human keratinocyte wound healing migration.
    Peñas PF; García-Díez A; Sánchez-Madrid F; Yáñez-Mó M
    J Invest Dermatol; 2000 Jun; 114(6):1126-35. PubMed ID: 10844555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of the motility of melanoma cells using interference RNA against CD9].
    Peñas PF; García-López MA; Barreiro del Río O
    Actas Dermosifiliogr; 2005; 96(1):30-6. PubMed ID: 16476329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetraspanin protein contributions to cancer.
    Wang HX; Li Q; Sharma C; Knoblich K; Hemler ME
    Biochem Soc Trans; 2011 Apr; 39(2):547-52. PubMed ID: 21428937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer.
    Funakoshi T; Tachibana I; Hoshida Y; Kimura H; Takeda Y; Kijima T; Nishino K; Goto H; Yoneda T; Kumagai T; Osaki T; Hayashi S; Aozasa K; Kawase I
    Oncogene; 2003 Feb; 22(5):674-87. PubMed ID: 12569360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphology and migration of podocytes are affected by CD151 levels.
    Blumenthal A; Giebel J; Ummanni R; Schlüter R; Endlich K; Endlich N
    Am J Physiol Renal Physiol; 2012 May; 302(10):F1265-77. PubMed ID: 22338088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility.
    Gesierich S; Paret C; Hildebrand D; Weitz J; Zgraggen K; Schmitz-Winnenthal FH; Horejsi V; Yoshie O; Herlyn D; Ashman LK; Zöller M
    Clin Cancer Res; 2005 Apr; 11(8):2840-52. PubMed ID: 15837731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation-induced internalization differs for the tetraspanins CD9 and Tspan8: Impact on tumor cell motility.
    Rana S; Claas C; Kretz CC; Nazarenko I; Zoeller M
    Int J Biochem Cell Biol; 2011 Jan; 43(1):106-19. PubMed ID: 20937409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD9/CD81 tetraspanin complex and tetraspanin CD151 regulate α3β1 integrin-dependent tumor cell behaviors by overlapping but distinct mechanisms.
    Gustafson-Wagner E; Stipp CS
    PLoS One; 2013; 8(4):e61834. PubMed ID: 23613949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing isoform complexity of human tetraspanins by optimized expression in Dictyostelium discoideum enables high-throughput functional read-out.
    Scheltz T; von Bülow J; Beitz E
    Protein Expr Purif; 2017 Jul; 135():8-15. PubMed ID: 28442431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells.
    Sauer G; Kurzeder C; Grundmann R; Kreienberg R; Zeillinger R; Deissler H
    Oncol Rep; 2003; 10(2):405-10. PubMed ID: 12579280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis.
    Wang HX; Sharma C; Knoblich K; Granter SR; Hemler ME
    Cell Res; 2015 Mar; 25(3):370-85. PubMed ID: 25656846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the tetraspanins CD9, CD37, CD63, and CD151 in Merkel cell carcinoma: strong evidence for a posttranscriptional fine-tuning of CD9 gene expression.
    Woegerbauer M; Thurnher D; Houben R; Pammer J; Kloimstein P; Heiduschka G; Petzelbauer P; Erovic BM
    Mod Pathol; 2010 May; 23(5):751-62. PubMed ID: 20118909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions.
    Yáñez-Mó M; Alfranca A; Cabañas C; Marazuela M; Tejedor R; Ursa MA; Ashman LK; de Landázuri MO; Sánchez-Madrid F
    J Cell Biol; 1998 May; 141(3):791-804. PubMed ID: 9566977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraspanin gene expression levels as potential biomarkers for malignancy of gingival squamous cell carcinoma.
    Hirano C; Nagata M; Noman AA; Kitamura N; Ohnishi M; Ohyama T; Kobayashi T; Suzuki K; Yoshizawa M; Izumi N; Fujita H; Takagi R
    Int J Cancer; 2009 Jun; 124(12):2911-6. PubMed ID: 19330835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DHHC2 affects palmitoylation, stability, and functions of tetraspanins CD9 and CD151.
    Sharma C; Yang XH; Hemler ME
    Mol Biol Cell; 2008 Aug; 19(8):3415-25. PubMed ID: 18508921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAM-A interacts with α3β1 integrin and tetraspanins CD151 and CD9 to regulate collective cell migration of polarized epithelial cells.
    Thölmann S; Seebach J; Otani T; Florin L; Schnittler H; Gerke V; Furuse M; Ebnet K
    Cell Mol Life Sci; 2022 Jan; 79(2):88. PubMed ID: 35067832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells.
    Longo N; Yáñez-Mó M; Mittelbrunn M; de la Rosa G; Muñoz ML; Sánchez-Madrid F; Sánchez-Mateos P
    Blood; 2001 Dec; 98(13):3717-26. PubMed ID: 11739177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel cysteine cross-linking method reveals a direct association between claudin-1 and tetraspanin CD9.
    Kovalenko OV; Yang XH; Hemler ME
    Mol Cell Proteomics; 2007 Nov; 6(11):1855-67. PubMed ID: 17644758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.
    Kohmo S; Kijima T; Otani Y; Mori M; Minami T; Takahashi R; Nagatomo I; Takeda Y; Kida H; Goya S; Yoshida M; Kumagai T; Tachibana I; Yokota S; Kawase I
    Cancer Res; 2010 Oct; 70(20):8025-35. PubMed ID: 20940407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.